Cargando…
GABA Measurement in a Neonatal Fragile X Syndrome Mouse Model Using (1)H-Magnetic Resonance Spectroscopy and Mass Spectrometry
Fragile X syndrome (FXS) is the leading monogenetic cause of autism spectrum disorder and inherited cause of intellectual disability that affects approximately one in 7,000 males and one in 11,000 females. In FXS, the Fmr1 gene is silenced and prevents the expression of the fragile X mental retardat...
Autores principales: | Reyes, Samantha T., Mohajeri, Sanaz, Krasinska, Karolina, Guo, Scarlett G., Gu, Meng, Pisani, Laura, Rosenberg, Jarrett, Spielman, Daniel M., Chin, Frederick T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775297/ https://www.ncbi.nlm.nih.gov/pubmed/33390902 http://dx.doi.org/10.3389/fnmol.2020.612685 |
Ejemplares similares
-
GABA and glutamate in the preterm neonatal brain: In-vivo measurement by magnetic resonance spectroscopy
por: Basu, Sudeepta K., et al.
Publicado: (2021) -
Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study
por: Bruno, Jennifer Lynn, et al.
Publicado: (2013) -
Simultaneous quantification of GABA, Glx and GSH in the neonatal human brain using magnetic resonance spectroscopy
por: Maria, Yanez Lopez, et al.
Publicado: (2021) -
Voxel Placement Precision for GABA-Edited Magnetic Resonance Spectroscopy
por: Bai, Xue, et al.
Publicado: (2017) -
Editorial: Magnetic Resonance Spectroscopy of GABA and Glutamate in Mental Health
por: Otaduy, Maria Concepcion Garcia
Publicado: (2022)